Post Profile






FDA places Regeneron and Teva's pain-drug study on hold

(Reuters) - Regeneron Pharmaceuticals Inc and partner Teva Pharmaceutical Industries Ltd said the U.S. health regulator placed a clinical hold on a study testing their pain treatment, dealing another blow to companies looking to develop a safer alternative to opioid painkillers.
read more

share

Related Posts


Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will The Transition Be Effective?

Business & Finance / Investing : Insider Monkey

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company in transition. Investors are currently not well-favore...

Momenta Pharmaceuticals, Inc. (MNTA) Latest to Take Advantage of Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Patent Woes

Business & Finance / Investing : Insider Monkey

The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). In June, it was determined that Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Sun unlawfully...

Is Teva Pharmaceutical Industries Ltd (TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?

A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)

Business & Finance / Investing : Insider Monkey

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) saw revenue fall 8% in the fourth quarter from a generic double whammy. Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and...

A $40.5 billion deal with Allergan will make Teva one of the biggest drug companies on the planet

Business & Finance : Business Insider: Money Game

TEL AVIV (Reuters) - Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a deal that will turn Teva into one of the top 10 pharmaceutical companies. The acquisition should help...

Comments


Copyright © 2016 Regator, LLC